University of East Anglia
Collaborator: Dr. Christopher Low, University of East Anglia
Health Categories:Cardiovascular Health
Research Summary: This project focused on the developing anti‐homocysteine formulations, and evaluating their effects on markers of cardiovascular diseases in humans.
SF Summarization: This project focused on developing formulations to reduce homocysteine (a risk factor for cardiovascular diseases) and evaluated the effects on the common markers of cardiovascular diseases.
Current Status: Completed
Stage: Clinical Study